Court Dismisses PhRMA Lawsuit Challenging IRA
IRA Drug Price Negotiation Program Litigation Updates – Denial of PI Motion and Motion to Dismiss in Chambers of Commerce Case and New Complaint Filed by Novo Nordisk
BREAKING NEWS – HHS Announces the First 10 Drugs Selected for IRA Drug Price Negotiation Program
Parties in Amgen v. Hospira Filgrastim Litigation Stipulate to Dismissal of All Claims
Senate Passes Bill on Advancing Education on Biosimilars
Subscribe: Subscribe via RSS
Blogs
Firm/Org